ArticleNature communications2025
Transformer-based deep learning enhances discovery in migraine GWAS.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated post-GWAS, single-cell, and functional analyses prioritizeFrontiers in immunology · 2026Article
- Transformer-based deep learning enhances discovery in migraine GWAS.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Migraine is a complex neurological disorder with substantial heritability, yet genome-wide association studies (GWAS) have explained only a fraction of its genetic component. We developed InsightGWAS, a Transformer-based model, to enhance genetic discovery for migraine by integrating functional annotations and leveraging transfer learning from GWAS datasets of major depressive disorder (MDD). Applying InsightGWAS to migraine GWAS datasets comprising 53,109 cases and 230,876 controls, we identified 293 previously unreported loci, influencing genes such as CACNA1D, HTR3C, and NLGN1, respectively. Furthermore, two loci rs4320030 (SCN11A) and rs5763529 (HORMAD2) were validated in independent sequencing studies, demonstrating the model's precision in uncovering migraine-associated loci. Compared to traditional GWAS results, enrichment analyses of InsightGWAS-predicted loci uncovered new signaling pathways, including nitrogen compound metabolism and cation binding, offering novel insights into the metabolic and ionic mechanisms underlying migraine susceptibility. These findings demonstrate the impact of InsightGWAS in complementing conventional approaches and advancing our understanding of migraine genetics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.